Results 191 to 200 of about 479,621 (361)

Hematologic Effects of Xylazine When Used for Restraint of Bactrian Camels [PDF]

, 1977
R. S. Custer, Lynn D. Kramer, Suzanne Kennedy, Mitchell Bush   +3 more
openalex   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring

Annals of Clinical and Translational Neurology, EarlyView.
Francesco Saccà, Ryan Pelto
wiley   +1 more source

Multi‐Responsive Dendrimer‐Hyaluronic Acid Hydrogel With Lubricating and Immunoregulatory Functions for Synergistic Osteoarthritis Therapy

Advanced Functional Materials, EarlyView.
A hydrogel with dynamic cross‐links was formed by cross‐linking hyaluronic acid with curcumin‐preloaded, phenylboronic acid‐modified poly(amidoamine) dendrimers. This hydrogel exhibited excellent injectability and self‐healing ability, enabling controlled Cur release in response to low pH, high reactive oxygen species (ROS) generation, or mechanical ...
Junjie Liu, Mengsi Zhan, Haoyu Huang, Jianhong Wang, Cheng Ni, Xiaojun Zhou, Hannah Küttner, Cong Song, Xiangyang Shi, Andrij Pich   +9 more
wiley   +1 more source

The Incidence of Hemolytic and Serologic Transfusion Reactions Among Patients with Hematological Malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute, in Uganda. [PDF]

J Blood Med
Taremwa IM, Niyonzima N, Ashaba S, Tusubira D, Choi MY, Jenne CN, van Marle G, Natukunda B.   +7 more
europepmc   +1 more source

Hematological emergencies

Annals of Oncology, 2007
N, Zojer, H, Ludwig
openaire   +2 more sources

Appraisal of current technologies for the study of genetic alterations in hematologic malignancies with a focus on chromosome analysis and structural variants [PDF]

Itziar Salaverría, Reiner Siebert, Krzysztof Mrózek   +2 more
openalex   +1 more source

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis [PDF]

, 2020
Surbhi Sidana, Paolo Milani, Moritz Binder, Marco Basset, Nidhi Tandon, Andrea Foli, Angela Dispenzieri, Morie A. Gertz, Suzanne R. Hayman, Francis K. Buadi, Martha Q. Lacy, Prashant Kapoor, Nelson Leung, S. Vincent Rajkumar, Giampaolo Merlini, Giovanni Palladini, Shaji Kumar   +16 more
openalex   +1 more source

Biomimetic Copper‐Doped Nano‐Aluminum Adjuvant Potentiates Therapy in Chemoresistant Acute Myeloid Leukemia

Advanced Healthcare Materials, EarlyView.
We developed a novel copper‐doped aluminum nano‐adjuvant (CuNA) to overcome cytarabine resistance in acute myeloid leukemia (AML). CuNA effectively sensitizes drug‐resistant AML cells to cytarabine by inducing mitochondrial dysfunction and inhibiting HMGCR/GPX4 to amplify ferroptosis.
Chao He, Lingxiao Zhang, Yue Xiong, Yu Wang, Yuqing Zeng, Dandan Su, Ran Wang, Ying Li, Hongbo Chen, Fang Cheng, Zhi Ping Xu   +10 more
wiley   +1 more source

Incidence and Comparative Risk of Hematological Adverse Events Across Different Immune Checkpoint Inhibitors: A Network Meta-Analysis of Randomized Controlled Trials. [PDF]

Cureus
Vajje J, Reyaz N, Gillani I, Muneeb Ullah M, Chaudhari SS, Jabeen S, Wei CR, Amin A.   +7 more
europepmc   +1 more source

Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologists

Dong Li, Sarah K. Tasian, Gerald Wertheim, Susan R. Rheingold, Kathrin M. Bernt, Haley Newman, Luanne Wainwright, Donna Wilmoth, Brian Thiel, Lea F. Surrey, Elizabeth Margolskee, Vinodh Pillai, Minjie Luo, Michele Paessler, Stephen P. Hunger, Marilyn M. Li, Yiming Zhong   +16 more
openalex   +2 more sources